ArticleFrontiers in oncology2025

GPD1L downregulation in colorectal cancer: a novel obesity-related biomarker linking metabolic dysregulation to tumor progression.

Feng Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.